Wed, Nov 26, 2014, 6:13 AM EST - U.S. Markets open in 3 hrs 17 mins


% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • macrosanuff macrosanuff Jul 26, 2014 7:36 AM Flag

    1. Best way to stop negative isis postings. Show just ONE SAFE isis drug in 25 years, ONE !

    Never mind the phony pipeline pump ! 2. Show just ONE ceo,cfo isis stock buy out of pocket without selling it in two minutes for the last 25 years! 3. Show just ONE ORAL approved isis drug that the ceo promised in 1999 was close at hand. These are just a few if you want more just let us know ! jetter go cry in your soup. SCRAM. No wonder investors love VICAL.

    Sentiment: Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • macro, you nailed it bullseye ! jetter could not answer and is twisted up in knots.

    • This isn't an Fxxxing trial in regards to ISIS or some government mandate. They are making huge progress at ISIS and even the RNAi blogger has come around and sees ISIS as the most powerful force in RNA at this time. Within two years they could have drugs on the market that is very valuable. No, the only way to rid the board of this from people like you is for VICL to go BK.......and I'm hoping and watching for that to happen. More so now than ever. Chances are high too. One more failure in the lab and they will be done. The good American workers there can probably latch onto another biotech. The CEO is highly suspect with running a trial and holding back on the info where the placebo patients did better than the treated patients. Short live VICL the sooner they die the better. And I'm waiting for it anxiously. Maybe a big failure by this year and they get delisted from the NSAD.......they are close now, no matter what spin you try and put on......t

51.51-0.9100(-1.74%)Nov 25 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.